Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Harvard Business School
Accenture
Julphar
Fuji
Cipla

Generated: April 25, 2018

DrugPatentWatch Database Preview

DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE Drug Profile

« Back to Dashboard

When do Diphenoxylate Hydrochloride W/ Atropine Sulfate patents expire, and when can generic versions of Diphenoxylate Hydrochloride W/ Atropine Sulfate launch?

Diphenoxylate Hydrochloride W/ Atropine Sulfate is a drug marketed by Scherer Rp and is included in one NDA.

The generic ingredient in DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
Drug patent expirations by year for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE

US Patents and Regulatory Information for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scherer Rp DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride CAPSULE;ORAL 086440-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Argus Health
Accenture
Fish and Richardson
Express Scripts
Julphar
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.